kıbrıs ingiltere londra lefkoşa
DOLAR
9,5111
EURO
11,0726
STERLIN
13,0942
BITCOIN
$59.151,74
Adana Adıyaman Afyon Ağrı Aksaray Amasya Ankara Antalya Ardahan Artvin Aydın Balıkesir Bartın Batman Bayburt Bilecik Bingöl Bitlis Bolu Burdur Bursa Çanakkale Çankırı Çorum Denizli Diyarbakır Düzce Edirne Elazığ Erzincan Erzurum Eskişehir Gaziantep Giresun Gümüşhane Hakkari Hatay Iğdır Isparta İstanbul İzmir K.Maraş Karabük Karaman Kars Kastamonu Kayseri Kırıkkale Kırklareli Kırşehir Kilis Kocaeli Konya Kütahya Malatya Manisa Mardin Mersin Muğla Muş Nevşehir Niğde Ordu Osmaniye Rize Sakarya Samsun Siirt Sinop Sivas Şanlıurfa Şırnak Tekirdağ Tokat Trabzon Tunceli Uşak Van Yalova Yozgat Zonguldak
LONDRA
Kapalı
17°C
LONDRA
17°C
Kapalı
Perşembe Az bulutlu
15°C
Cuma Orta şiddetli yağmur
="http://www.w3.org/2000/svg" viewBox="0 0 300 300" enable-background="new 0 0 300 300">
13°C
Cumartesi Hafif yağmur
="http://www.w3.org/2000/svg" viewBox="0 0 300 300" enable-background="new 0 0 300 300">
14°C
Pazar az bulutlu
="http://www.w3.org/2000/svg" viewBox="0 0 300 300" enable-background="new 0 0 300 300">
12°C

Artificial pancreas may soon be available on the NHS 

Artificial pancreas may soon be available on the NHS 
16.09.2021
0
A+
A-

AN artificial pancreas to manage type 1 diabetes could soon be offered to NHS patients after a major trial produced ‘blisteringly brilliant’ early results.

The high-tech kit continuously monitors glucose levels via sensors under a patient’s skin and, when needed, automatically delivers insulin to the bloodstream – a job normally carried out in the body by the pancreas.

It is hoped it will replace the regular finger-prick tests that diabetics need to carry out to check their blood sugar levels, as well as prevent life-threatening hypoglycaemic attacks when it drops too low.

As part of an appraisal carried out by the NHS spending watchdog, the National Institute for Health and Care Excellence (NICE), 1,000 Britons with type 1 diabetes are being fitted with one of the gadgets.

The artificial pancreas trial, the largest of its kind in the world, began in July and health chiefs are expected to come to a decision next year on whether to begin offering them widely.

Doctors on the new NHS trial say the artificial pancreas is ‘overwhelmingly effective’ at reducing the burden of living with type 1 diabetes and is capable of improving the long-term health of patients.

Professor Partha Kar, diabetes consultant at Portsmouth Hospitals NHS Trust and National Specialty Adviser to NHS England, said: ‘This is the first time this tech has been rolled out to so many patients, and already we can see it is blisteringly brilliant. This could be potentially life-changing.

So much of diabetes patients’ lives are filled with self-management – doing fingerprick tests, making calculations to determine how much insulin they need. With the artificial pancreas, that’s all basically removed. This really is the future of diabetes care.’

 

 

Yorumlar

Henüz yorum yapılmamış. İlk yorumu yukarıdaki form aracılığıyla siz yapabilirsiniz.